Key facts
- This page summarizes Samuel Rubinstein's Form 4 filing for MediWound Ltd. (MDWD).
- 2 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 02 Sep 2026, 16:02.
Samuel Rubinstein - 01 Sep 2026 Form 4 Insider Report for MediWound Ltd. (MDWD)
- Reporting relationship
- Director
- Issuer ticker
- MDWD
- Reported as of
- 01 Sep 2026
- Net transaction value
- -$52.5
- SEC form
- 4
- Accepted by SEC
- 02 Sep 2026, 16:02:42 UTC
- Prior SEC filing
- 01 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Yaron Meyer, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Samuel Rubinstein filed Form 4 for MediWound Ltd. (MDWD) on 02 Sep 2026.
Change
- Previous filing in this sequence was filed on 01 Jun 2026.
- Current net transaction value: -$52.5.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001742152
Primary reporting owner
Rubinstein Samuel
- Relationship
- Director
- Address
- C/O MEDIWOUND LTD., 42 HAYARKON STREET, YAVNE, ISRAEL
- Signature
- /s/ Yaron Meyer, attorney-in-fact
- Signature date
- 02 Sep 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MDWD
transaction
Ordinary Shares
Sale
- Transaction value
- $6,678
- Shares
- -525
- Change %
- -100%
- Price
- $12.72
- Shares after
- 0
- Date
- 01 Sep 2026
- Ownership
- By spouse
MDWD
transaction
Ordinary Shares
Purchase
- Transaction value
- $6,626
- Shares
- +525
- Change %
- Price
- $12.62
- Shares after
- 525
- Date
- 01 Sep 2026
- Ownership
- By spouse
MDWD
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,993
- Date
- 01 Sep 2026
- Ownership
- Direct
- Footnotes
- F2
MDWD
holding
Ordinary shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 750
- Date
- 01 Sep 2026
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MDWD
holding
Derivative
Stock Option (right to buy ordinary shares)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 7,200
- Date
- 01 Sep 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 7,200
- Exercise price
- $9.64
- Footnotes
- F2
MDWD
holding
Derivative
Stock Option (right to buy ordinary shares)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 7,542
- Date
- 01 Sep 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 7,542
- Exercise price
- $12.73
- Footnotes
- F2
MDWD
holding
Derivative
Stock Option (right to buy ordinary shares)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 5,600
- Date
- 01 Sep 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 5,600
- Exercise price
- $18.54
- Footnotes
- F2
MDWD
holding
Derivative
Stock Option (right to buy ordinary shares)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 6,250
- Date
- 01 Sep 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 6,250
- Exercise price
- $17.60
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date.
Footnote F2
There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
Footnote F3
The options reported in this row were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date.
SEC remarks
The Issuer is a foreign private issuer as defined under Rule 3b-4 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). In accordance with Rule 3a12-3(b) under the Exchange Act, the Reporting Person is exempt from the short-swing profit recovery provisions of Section 16(b) of the Exchange Act.